Exercise increases the binding of MEF2A to the Cpt1b promoter in mouse skeletal muscle

Acta Physiologica

Volumn 212, Issue 4, 2014, Pages 283-292

  Yuan, H ^a   Niu, Y ^a   Liu, X ^a   Fu, L ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Acetylation; Cpt1b; Exercise; HDAC5; Histone deacetylase 3; MEF2

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CPT1B PROTEIN, MOUSE; MEF2A PROTEIN, MOUSE; MYOCYTE ENHANCER FACTOR 2; PROTEIN BINDING;

ADAPTATION; ANIMAL; ANIMAL EXPERIMENT; C57BL MOUSE; MALE; METABOLISM; MOUSE; MUSCLE CONTRACTION; PHYSIOLOGY; PROCEDURES; PROMOTER REGION; SKELETAL MUSCLE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; MALE; MEF2 TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; PROMOTER REGIONS, GENETIC; PROTEIN BINDING;

EID: 84920273164     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12395     Document Type: Article

References (27)

1. Angelelli, C., Magli, A., Ferrari, D., Ganassi, M., Matafora, V., Parise, F., Razzini, G., Bachi, A., Ferrari, S. & Molinari, S. 2008. Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells. Nucleic Acids Res 36, 915-928.
2. Baldán, A., Relat, J., Marrero, P.F. & Haro, D. 2004. Functional interaction between peroxisome proliferator-activated receptors-alpha and Mef-2C on human carnitine palmitoyltransferase 1beta (CPT1beta) gene activation. Nucleic Acids Res 32, 4742-4749.
3. Bonnefont, J.P., Djouadi, F., Prip-Buus, C., Gobin, S., Munnich, A. & Bastin, J. 2004. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 25, 495-520.
4. Brand, N.J. 1997. Myocyte enhancer factor 2 (MEF2). Int J Biochem Cell Biol 29, 1467-1470.
5. Egan, B. & Zierath, J.R. 2013. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 17, 162-184.
6. Fernando, P., Bonen, A. & Hoffman-Goetz, L. 1993. Predicting submaximal oxygen consumption during treadmill running in mice. Can J Physiol Pharmacol 71, 854-857.
7. Fu, L., Liu, X., Niu, Y., Yuan, H., Zhang, N. & Lavi, E. 2012. Effects of high-fat diet and regular aerobic exercise on global gene expression in skeletal muscle of C57BL/6 mice. Metabolism 61, 146-152.
8. Grégoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E. & Yang, X.J. 2007. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol 27, 1280-1295.
9. Haberland, M., Montgomery, R.L. & Olson, E.N. 2009. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10, 32-42.
10. Liu, X., Yuan, H., Niu, Y., Niu, W. & Fu, L. 2012. The role of AMPK/mTOR/S6K1 signaling axis in mediating the physiological process of exercise-induced insulin sensitization in skeletal muscle of C57BL/6 mice. Biochim Biophys Acta 1822, 1716-1726.
11. McCall, A. & Raj, R. 2009. Exercise for prevention of obesity and diabetes in children and adolescents. Clin Sports Med 28, 393-421.
12. McGee, S.L. 2007. Exercise and MEF2-HDAC interactions. Appl Physiol Nutr Metab 32, 852-856.
13. McGee, S.L., Sparling, D., Olson, A.L. & Hargreaves, M. 2006. Exercise increases MEF2- and GEF DNA-binding activity in human skeletal muscle. FASEB J 20, 348-349.
14. McGee, S.L., Fairlie, E., Garnham, A.P. & Hargreaves, M. 2009. Exercise-induced histone modifications in human skeletal muscle. J Physiol 587, 5951-5958.
15. Mihaylova, M.M. & Shaw, R.J. 2013. Metabolic reprogramming by class I and II histone deacetylases. Trends Endocrinol Metab 24, 48-57.
16. Mihaylova, M.M., Vasquez, D.S., Ravnskjaer, K., Denechaud, P.D., Yu, R.T., Alvarez, J.G., Downes, M., Evans, R.M., Montminy, M. & Shaw, R.J. 2011. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145, 607-621.
17. Moore, M.L., Wang, G.L., Belaguli, N.S., Schwartz, R.J. & McMillin, J.B. 2001. GATA-4 and serum response factor regulate transcription of the muscle-specific carnitine palmitoyltransferase I beta in rat heart. J Biol Chem 276, 1026-1033.
18. Moore, M.L., Park, E.A. & McMillin, J.B. 2003. Upstream stimulatory factor represses the induction of carnitine palmitoyltransferase-Ibeta expression by PGC-1. J Biol Chem 278, 17263-17268.
19. Niu, Y., Yuan, H. & Fu, L. 2010. Aerobic exercise's reversal of insulin resistance by activating AMPK alpha-ACC-CPT1 signaling in the skeletal muscle of C57BL/6 mice. Int J Sport Nutr Exerc Metab 20, 370-380.
20. Philp, A., Mackenzie, M.G., Belew, M.Y., Towler, M.C., Corstorphine, A., Papalamprou, A., Hardie, D.G. & Baar, K. 2013. Glycogen content regulates peroxisome proliferator activated receptor- partial differential (PPAR- partial differential) activity in rat skeletal muscle. PLoS One 8, e77200.
21. Potthoff, M.J., Wu, H., Arnold, M.A., Shelton, J.M., Backs, J., McAnally, J., Richardson, J.A., Bassel-Duby, R. & Olson, E.N. 2007. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 117, 2459-2467.
22. Smith, C.L. 2008. A shifting paradigm: histone deacetylases and transcriptional activation. BioEssays 30, 15-24.
23. Vega, R.B., Huss, J.M. & Kelly, D.P. 2000. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 20, 1868-1876.
24. Yamazaki, N., Yamanaka, Y., Hashimoto, Y., Shinohara, Y., Shima, A. & Terada, H. 1997. Structural features of the gene encoding human muscle type carnitine palmitoyltransferase I. FEBS Lett 409, 401-406.
25. Ye, J. 2013. Improving insulin sensitivity with HDAC inhibitor. Diabetes 62, 685-687.
26. Yuan, H., Niu, Y., Liu, X., Yang, F., Niu, W. & Fu, L. 2013. Proteomic analysis of skeletal muscle in insulin-resistant mice: response to 6-week aerobic exercise. PLoS One 8, e53887.
27. Zhao, X., Sternsdorf, T., Bolger, T.A., Evans, R.M. & Yao, T.P. 2005. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol Cell Biol 25, 8456-8464.